LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer

References

• Jin G, Lv J, Yang M, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020;21(10):1378–1386.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648.
   PubMed Web of Science ®Google Scholar
• Barekzai AM, Aminianfar A, Mousavi SM, et al. The Association between Dietary inflammatory potential and gastric cancer: a Case Control Study. Nutr Cancer 2021 1–10 10.1080/01635581.2021.2014906
   Web of Science ®Google Scholar
• Goksoy B, Bozkurt H. Social attention of the top 50 scientific articles on gastric cancer: bibliometric and altmetric analysis. J Buon. 2020;25(5):2322–2331.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021;15:S1044-579X(21)00059–6.
   Google Scholar
• Wu JY, Lee YC, Graham DY. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev Gastroenterol Hepatol. 2019;13(1):17–24.
   PubMed Web of Science ®Google Scholar
• Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–542.
   PubMed Web of Science ®Google Scholar
• Kong X, Duan Y, Sang Y, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105–9117.
   PubMed Web of Science ®Google Scholar
• Deng D, Mo Y, Xue L, et al. Long non-coding RNA SUMO1P3 promotes tumour progression by regulating cell proliferation and invasion in glioma. Exp Ther Med. 2021;21(5):491.
   PubMed Web of Science ®Google Scholar
• Nie W, Hu MJ, Zhang Q, et al. DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation. Acta Pharmacol Sin. 2022;43(1):157–166.
   PubMed Web of Science ®Google Scholar
• Mu B, Lv C, Liu Q, et al. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis. J Biochem. 2021;170(1):41–50.
   PubMed Web of Science ®Google Scholar
• Xu Y, Qiu M, Shen M, et al. The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther. 2021;29(7):2209–2218.
   PubMed Web of Science ®Google Scholar
• Ma L, Jiang Y, Wu N. Long non-coding RNA CCL2 promoted gastric cancer function via miR-128/ PARP2 signal pathway. Bioengineered. 2022;13(1):1602–1611.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu X, Luo N, et al. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer. Bioengineered. 2021;12(2):12931–12939.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qin B. Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer. Gastric Cancer. 2019;22(4):692–704.
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Zhang M, et al. LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a. Mol Ther Nucleic Acids. 2020;19:109–123.
   PubMedGoogle Scholar
• Zhang E, He X, Zhang C, et al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018;19(1):154.
   PubMed Web of Science ®Google Scholar
• Han Y, Wu N, Jiang M, et al. Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer. Cell Prolif. 2019;52(6):e12678.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu L, Li W, et al. Long Noncoding RNA LINC01485 Promotes Tumor Growth and Migration via Inhibiting EGFR Ubiquitination and Activating EGFR/Akt Signaling in Gastric Cancer. Onco Targets Ther. 2020;13:8413–8425.
   PubMed Web of Science ®Google Scholar
• Wang S, Guo X, Lv W, et al. LncRNA RPSAP52 Upregulates TGF-beta1 to Increase Cancer Cell Stemness and Predict Postoperative Survival in Glioblastoma. Cancer Manag Res. 2020;396:2541–2547.
   Google Scholar
• Ros G, Pegoraro S, De Angelis P, et al. HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion. Front Oncol. 2019;9:1526.
   PubMed Web of Science ®Google Scholar
• D’Angelo D, Arra C, Fusco A. RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR. Oncol Res. 2020;28(2):191–201.
   PubMed Web of Science ®Google Scholar
• Wu KZ, Zhang CD, Zhang C, et al. miR-665 Suppresses the Epithelial-Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1. Cancer Manag Res. 2020;12:3489–3501.
   PubMed Web of Science ®Google Scholar
• Guo T, Wang W, Ji Y, et al. LncRNA PROX1-AS1 Facilitates Gastric Cancer Progression via miR-877-5p/PD-L1 Axis. Cancer Manag Res. 2021;13:2669–2680.
   PubMed Web of Science ®Google Scholar
• Pan T, Yu Z, Jin Z, et al. Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids. 2021;23:1288–1303.
   PubMedGoogle Scholar
• Zhong X, Wen X, Chen L, et al. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis. J Gene Med. 2021;23:e3330.
   PubMed Web of Science ®Google Scholar
• Wu X, Gong Z, Ma L, et al. lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2. J Cell Mol Med. 2021;25(10):4744–4752.
   PubMed Web of Science ®Google Scholar
• D’Angelo D, Mussnich P, Sepe R, et al. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins. J Mol Med (Berl). 2019;97(7):1019–1032.
   PubMed Web of Science ®Google Scholar
• Niu T, An Y, Lv T, et al. Long non-coding RNA RPSAP52 upregulates Timp3 by serving as the endogenous sponge of microRNA-365 in diabetic retinopathy. Exp Ther Med. 2020;20(6):246.
   PubMed Web of Science ®Google Scholar
• Chen J, Zheng Y, Li L. LncRNA RPSAP52 regulates miR-423-5p/GSTM1 axis to suppress hypoxia-induced renal proximal tubular epithelial cell apoptosis. Arch Physiol Biochem. 2020;1–5. DOI:10.1080/13813455.2020.1750657
   Web of Science ®Google Scholar
• Shi X, You X, Zeng WC, et al. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p. Eur Rev Med Pharmacol Sci. 2019;23(24):10761–10768.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang M, He P. LncRNA NEAT1 Promotes the Progression of Gastric Cancer Through Modifying the miR-1224-5p/RSF1 Signaling Axis. Cancer Manag Res. 2020;12:11845–11855.
   PubMed Web of Science ®Google Scholar
• Ma HF, He WW, Wang JJ. Long noncoding RNA LINC00858 promotes the proliferation, migration and invasion of gastric cancer cells via the miR-363-3p/FOXP4 axis. Eur Rev Med Pharmacol Sci. 2020;24(18):9391–9399.
   PubMed Web of Science ®Google Scholar
• Zhang T, Jing B, Bai Y, et al. Circular RNA circTMEM45A Acts as the Sponge of MicroRNA-665 to Promote Hepatocellular Carcinoma Progression. Mol Ther Nucleic Acids. 2020;22:285–297.
   PubMedGoogle Scholar
• Zhao J, Yang T, Ji J, et al. RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer. Cancer Gene Ther. 2021;28(1–2):33–41.
   PubMed Web of Science ®Google Scholar
• Ouyang S, Zhou X, Chen Z, et al. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 2019;19(1):72.
   PubMedGoogle Scholar
• Zhang M, Wang S, Yi A, et al. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A. Cell Biochem Funct. 2020;38(4):409–418.
   PubMed Web of Science ®Google Scholar
• Hu J, Ni G, Mao L, et al. LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis. Onco Targets Ther. 2019;12:7865–7875.
   PubMed Web of Science ®Google Scholar
• Yang H, Xu W. STAT3 promotes peritoneal metastasis of gastric cancer by enhancing mesothelial-mesenchymal transition. Biol Chem. 2021;402(6):739–748.
   PubMed Web of Science ®Google Scholar
• Yang YL, Liu P, Li D, et al. Stat-3 signaling promotes cell proliferation and metastasis of gastric cancer through PDCD4 downregulation. Kaohsiung J Med Sci. 2020;36(4):244–249.
   PubMed Web of Science ®Google Scholar
• Xu Y, Feng S, Niu B. Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line. Biotech Histochem. 2021;96(1):76–81.
   PubMed Web of Science ®Google Scholar